纵向评估尿PCA3对主动监测中有利风险男性前列腺癌分级重新分类的预测价值
本研究评估尿PCA3一次性检测和纵向变化对主动监测中有利风险前列腺癌男性分级重新分类的预测价值。260名男性中28人(11%)发生分级重新分类,分级重新分类者首次和后续PCA3评分均更高,但PCA3变化率无差异;多变量模型中首次PCA3仍与分级重新分类显著相关。
要点
- 分级重新分类者首次PCA3中位数48.0 vs 未分级重新分类者24.5(P=0.007)。
- 分级重新分类者后续PCA3中位数63.5 vs 未分级重新分类者36.0(P=0.002)。
- PCA3纵向变化率在分级重新分类状态间无差异(P=0.53)。
核心结论
- 主动监测期间获取的PCA3评分在接受分级重新分类的男性中更高,但PCA3随时间的变化率在分级重新分类状态间无差异。
- 在包含常规风险因素的多变量模型中,PCA3是分级重新分类的显著预测因子,提示PCA3在主动监测环境中提供增量预后信息。
研究设计与样本
- 约翰霍普金斯主动监测项目对有利风险前列腺癌男性进行系列PSA、直肠指检(DRE)、前列腺磁共振成像和前列腺活检监测。
- 自2007年起常规获取DRE后尿液标本,纳入监测≥3年期间获得多次PCA3测量的男性,共260人符合研究标准。
主要发现
- 从入组到首次PCA3的中位时间为2年(IQR 1-3),从首次PCA3到后续PCA3的中位时间为5年(IQR 4-6)。
- 中位随访6年(IQR 5-8)期间,28人(11%)发生Gleason分级重新分类(Gleason评分>6)。
- 分级重新分类者首次PCA3中位数48.0 vs 未分级重新分类者24.5(P=0.007),后续PCA3中位数63.5 vs 36.0(P=0.002)。
- PCA3纵向变化在分级重新分类状态间无差异(对数归一化速率0.07 vs 0.06,P=0.53)。
- 在包含年龄、风险分类和PSA密度的多变量模型中,首次PCA3仍与分级重新分类显著相关(log(fPCA3)比值比=1.77,P=0.04)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To assess the utility of urinary prostate cancer antigen 3 (PCA3) as both a one-time and longitudinal measure in men on active surveillance (AS). METHODS: The Johns Hopkins AS program monitors men with favorable-risk prostate cancer with serial PSA, digital rectal examination (DRE), prostate magnetic resonance imaging and prostate biopsy. Since 2007, post-DRE urinary specimens have also been routinely obtained. Men with multiple PCA3 measures obtained over ⩾3 years of monitoring were included. Utility of first PCA3 score (fPCA3), subsequent PCA3 (sPCA3) and change in PCA3 were assessed for prediction of Gleason grade reclassification (GR, Gleason score >6) during follow-up. RESULTS: In total, 260 men met study criteria. Median time from enrollment to fPCA3 was 2 years (interquartile range (IQR) 1-3) and from fPCA3 to sPCA3 was 5 years (IQR 4-6). During median follow-up of 6 years (IQR 5-8), 28 men (11%) underwent GR. Men with GR had higher median fPCA3 (48.0 vs 24.5, P=0.007) and sPCA3 (63.5 vs 36.0, P=0.002) than those without GR, while longitudinal change in PCA3 did not differ by GR status (log-normalized rate 0.07 vs 0.06, P=0.53). In a multivariable model including age, risk classification and PSA density, fPCA3 remained significantly associated with GR (log(fPCA3) odds ratio=1.77, P=0.04). CONCLUSIONS: PCA3 scores obtained during AS were higher in men who underwent GR, but the rate of change in PCA3 over time did not differ by GR status. PCA3 was a significant predictor of GR in a multivariable model including conventional risk factors, suggesting that PCA3 provides incremental prognostic information in the AS setting.
引用
- Tosoian JJ, Patel HD, Mamawala M, et al. Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance. Prostate Cancer Prostatic Dis. 2017. PMID: 28417979. doi:10.1038/pcan.2017.16
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。